Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep
International Journal of Molecular Sciences · 19.02.2024 · 25 (4) · 2413
DOI: 10.3390/ijms25042413 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2024. Verfasst von Timo Steinkühler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Hauptthemen laut MEDLINE: Lung Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This project was supported by a medical research grant from Sedana Medical (Danderdyd, Sweden), who provided 12 Sedconda devices, 25 Sedaconda syringes and 1 f…, Sedana Medical (Danderdyd, Sweden), University Medical Centre Groningen transplant research fund.
Abstract (Originalsprache)
Volatile anesthetics have been shown in different studies to reduce ischemia reperfusion injury (IRI). Ex vivo lung perfusion (EVLP) facilitates graft evaluation, extends preservation time and potentially enables injury repair and improvement of lung quality. We hypothesized that ventilating lungs with sevoflurane during EVLP would reduce lung injury and improve lung function. We performed a pilot study to test this hypothesis in a slaughterhouse sheep DCD model. Lungs were harvested, flushed and stored on ice for 3 h, after which EVLP was performed for 4 h. Lungs were ventilated with either an FiO2 of 0.4 (EVLP, n = 5) or FiO2 of 0.4 plus sevoflurane at a 2% end-tidal concentration (Cet) (S-EVLP, n = 5). Perfusate, tissue samples and functional measurements were collected and analyzed. A steady state of the target Cet sevoflurane was reached with measurable concentrations in perfusate. Lungs in the S-EVLP group showed significantly better dynamic lung compliance than those in the EVLP group (p = 0.003). Oxygenation capacity was not different in treated lungs for delta partial oxygen pressure (PO2; +3.8 (−4.9/11.1) vs. −11.7 (−12.0/−3.2) kPa, p = 0.151), but there was a trend of a better PO2/FiO2 ratio (p = 0.054). Perfusate ASAT levels in S-EVLP were significantly reduced compared to the control group (198.1 ± 93.66 vs. 223.9 ± 105.7 IU/L, p = 0.02). We conclude that ventilating lungs with sevoflurane during EVLP is feasible and could be useful to improve graft function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Thoracic Surgery, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Basic and Applied Medical Sciences, Ghent University, 9000 Ghent, Belgium.
- Department of Critical Care, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Perioperative Medicine, University Hospital Clermont-Ferrand, 63001 Clermont-Ferrand, France.
- Institute of Genetics, Reproduction & Development, University Clermont Auvergne, 63001 Clermont-Ferrand, France.
ORCID-Profile: Timo Steinkühler, Shuqi Yang, Matthieu Jabaudon, Wim Timens, Gertrude J Nieuwenhuijs-Moeke
Förderung
- This project was supported by a medical research grant from Sedana Medical (Danderdyd, Sweden), who provided 12 Sedconda devices, 25 Sedaconda syringes and 1 f…
- Sedana Medical (Danderdyd, Sweden)
- University Medical Centre Groningen transplant research fund
- Astellas Transplantation Research Price
- Dutch Society of Transplantation
Zitieren
APA
Steinkühler, T., Yang, S., Hu, M. A., Jainandunsing, J. S., Jager, N. M., Erasmus, M. E., Struys, M. M. R. F., Bosch, D. J., van Meurs, M., Jabaudon, M., Richard, D., Timens, W., Leuvenink, H. G. D., & Nieuwenhuijs-Moeke, G. J. (2024). Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep. International Journal of Molecular Sciences, 25(4), 2413. https://doi.org/10.3390/ijms25042413
Vancouver
Steinkühler T, Yang S, Hu MA, Jainandunsing JS, Jager NM, Erasmus ME, et al. Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep. International Journal of Molecular Sciences. 2024;25(4):2413. doi:10.3390/ijms25042413
BibTeX
@article{Steinkhler2024,
author = {Steinkühler, Timo and Yang, Shuqi and Hu, Michiel A and Jainandunsing, Jayant S and Jager, Neeltina M and Erasmus, Michiel E and Struys, Michel M R F and Bosch, Dirk J and van Meurs, Matijs and Jabaudon, Matthieu and Richard, Damien and Timens, Wim and Leuvenink, Henri G D and Nieuwenhuijs-Moeke, Gertrude J},
title = {Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {4},
pages = {2413},
doi = {10.3390/ijms25042413}
}
EUVIMED